News

WinRho SDF is used to treat immune thrombocytopenic purpura (ITP), a critical autoimmune bleeding disorder. Baxter currently markets WinRho SDF for Cangene in the UK and intends to

The phase I clinical study is designed as an open label single dose escalation safety study in patients with chemo-refractive ovarian cancer. MORAb-003 is a monoclonal antibody that

The age-related macular degeneration (AMD) research initiative will be led by Dr Gregory Hageman, professor at the UI Carver College of Medicine. “The molecular events leading to the

Clevelox is an investigational drug undergoing phase III clinical trials as an agent to reduce blood pressure in cardiac surgery. Trial enrollment was halted after a planned interim

The Therapeutic Goods Administration (TGA) defines orphan drug products as “drugs, vaccines or in vivo diagnostic agents which physicians use to treat, prevent or diagnose rare diseases.” The

Under the terms of the agreement, Tanox will receive all tissue factor antagonist assets from Sunol, including anti-tissue factor monoclonal antibodies and related technologies and intellectual properties, as

The two studies were designed to evaluate whether adding Targretin (bexarotene) capsules to front-line cisplatin/vinorelbine or carboplatin/paclitaxel chemotherapy extends the survival of patients with advanced non-small cell lung

The agreement covers the development and commercialization of most of Dr Reddy’s abbreviated new drug applications (ANDAs) to be filed in 2004-05 and 2005-06. Under the terms of

The TriActiv System, according to Kensey Nash, is an embolic protection device used during percutaneous coronary intervention of diseased saphenous vein grafts. It aims to prevent material or